|
|
|
|
The obesity drug development landscape is rapidly evolving, but despite this promising trajectory, significant barriers in patient recruitment and retention persist. To combat these challenges, innovative patient-centric strategies are being employed, including mobile research and community-based clinical trial sites.
|
|
|
|
|
Traditional trial models often struggle to recruit minority populations due to logistical barriers, but community-based approaches significantly improve accessibility and engagement. Learn how sites effectively manage complex trials while maintaining high standards of care by confronting misconceptions about community-based research.
|
|
|
|
|
Traditional brick-and-mortar clinical sites have long been the backbone of clinical trials, but in recent years, we've seen an accelerated shift toward hybrid and decentralized designs. Delve into the significance of evolving clinical trial models and their potential to remove barriers to participation.
|
|
|
|
|
Clinical trial accessibility in the U.S. reveals significant disparities due to healthcare deserts, particularly in rural and underserved regions. Using recent data, let's examine how these gaps affect trial participation and discuss potential strategies to enhance access and equity.
|
|
|
|
|
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
|
|
|
